Publications (last 2 years)

1. Jorgensen SCJ, Trinh TD, Zasowski EJ, Lagnf AM, Simon SP, Bhatia S, Melvin SM, Steed ME, Finch NA, Morrisette T, Estrada SJ, Rosenberg JR, Davis SL, Rybak MJ. Real-world experience with ceftolozane-tazobactam for multidrug-resistant gram-negative bacterial infections. Antimicrob Agents Chemother. Jan 2020. doi: 10.1128/AAC.02291-19.
2. Sara Alosaimy, Jacinda C. Abdul-Mutakabbir, Razie Kebriaei, Sarah CJ Jorgensen, Rybak MJ. Evaluation of Eravacycline: A Novel Flourocycline. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. Jan 2020. doi: 10.1002/phar.2366.
3. Sarah C. J. Jorgensen, Kyle P. Murray, Adalhamid M. Lagnf, Sarah Melvin, Sahil Bhatia, Muhammed-Daniayl Shamim, Jordan R. Smith, Karrine D. Brade, Samuel P. Simon, Jerod Nagel, Karen S. Williams, Jessica K. Ortwine, Michael P. Veve, James Truong, David B. Huang, Susan L. Davis, Rybak MJ. A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections. Infectious Diseases and Therapy. Jan 2020. Doi:10.1007/s40121-019-00278-1.
4. Sarah C. J. Jorgensen, Trinh TD, Evan J. Zasowski, Abdalhamid M. Lagnf, Sahil Bhatia, Sarah M. Melvin, Samuel P. Simon, Joshua R. Rosenberg, Molly E. Steed, Sandra J. Estrada, Taylor Morrisette, Susan L. Davis, Rybak MJ. Evaluation of the Increment-CPE, Pitt Bacteremia and qPitt Scores in Patients with Carbapenem-Resistant Enterobacteriaceae Infections Treated with Ceftazidime-Avibactam. Infectious Disease and Therapy. February 2020. Doi: 10.1007/s40121-020-00288-4
5. Jahanbakhsh S, Singh NB, Yim J, Kebriaei R, Smith JR, Lev K, Tran TT, Rose WE, Arias CA, Rybak MJ. Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e02074-19. doi: 10.1128/AAC.02074-19. PMID: 32094136; PMCID: PMC7179592.
6. Rybak MJ, Le J, Lodise TP, et al. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2020;40(4):363-367. doi:10.1002/phar.2376.
7. Alosaimy S, Sabagha NL, Lagnf AM, Zasowski EJ, Morrisette T, Jorgensen SCJ, Trinh TD, Mynatt RP, Rybak MJ. Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: A Retrospective Cohort Analysis. Infect Dis Ther (2020). https://doi.org/10.1007/s40121-020-00292-8
8. Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020;77(11):835-864. doi:10.1093/ajhp/zxaa036
9. Jamie L. Wagner, Nathaniel J. Rhodes, Marc H. Scheetz, John A. Bosso, Debra A. Goff, Rybak MJ, Susan L. Davis. Opportunities for antimicrobial stewardship among carbapenem-treated patients in 18 North American hospitals [published online ahead of print, 2020 Apr 10]. Int J Antimicrob Agents. 2020;105970. doi:10.1016/j.ijantimicag.2020.105970.
10. Lodise TP, Rybak MJ. COVID-19: Important Therapy Considerations and Approaches in this Hour of Need [published online ahead of print, 2020 Apr 8]. Pharmacotherapy. 2020;10.1002/phar.2396. doi:10.1002/phar.2396.
11. Kebriaei, Razieh; Rice, Seth; Singh, Nivedita; Stamper, Kyle; nguyen, logan; Sheikh, zain; Rybak MJ. Combinations of (lipo) glycopeptides with β-lactams against MRSA: susceptibility insights [published online ahead of print, 2020 Jun 26]. J Antimicrob Chemother. 2020;dkaa237. doi:10.1093/jac/dkaa237
12. Kebriaei R, Lev K, Morrisette, Kyle Stamper, Jacinda C. Abdul-Mutakabbir, Susan M. Lehman, Sandra Morales, Rybak MJ. Bacteriophage-Antibiotic Combination Strategy: An Alternative against Methicillin-resistant Phenotypes of Staphylococcus aureus [published online ahead of print, 2020 May 11]. Antimicrob Agents Chemother. 2020; AAC.00461-20. doi:10.1128/AAC.00461-20
13. Morrisette T, Lagnf AM, Alosaimy S, Rybak MJ. A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli [published online ahead of print, 2020 Jun 13]. Eur J Clin Microbiol Infect Dis. 2020;10.1007/s10096-020-03941-5. doi:10.1007/s10096-020-03941-5
14. Razieh Kebriaei, Kyle C. Stamper, Kavindra V. Singh_,  Ayesha Khan, Seth A. Rice, An Q. Dinh, Truc T. Tran, Barbara E. Murray, Cesar A. Arias., Rybak MJ_.  Mechanistic Insights into the Differential Efficacy of Daptomycin plus β-Lactam Combinations against Daptomycin-Resistant Enterococcus faecium [published online ahead of print, 2020 Jun 8]. J Infect Dis. 2020; jiaa319. doi:10.1093/infdis/jiaa319
15. Kale-Pradhan PB, Giuliano C, Jongekrijg A, Rybak MJ. Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics - A Meta-analysis [published online ahead of print, 2020 Jun 13]. Pharmacotherapy. 2020;10.1002/phar.2437. doi:10.1002/phar.2437
16. Taylor Morrisette, Katherine L. Lev, Razieh Kebriaei, Jacinda Abdul-Mutakabbir, Kyle C. Stamper, Sandra Morales, Susan M. Lehman, Gregory S. Canfield, Breck A. Duerkop, Gregory S. Canfield, Cesar A. Arias, Rybak MJ. Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying in the Treatment of Methicillin-resistant Staphylococcus aureus Complicated Skin and Soft Tissue Infections [published online ahead of print, 2020 Jul 27]. Clin Infect Dis. 2020;ciaa1039. doi:10.1093/cid/ciaa1039
17. Razieh Kebriaei, Seth A Rice, Nivedita B Singh, Kyle C Stamper, Logan Nguyen, Zain Sheikh, Rybak MJ. Combinations of (lipo)glycopeptides with β-lactams against MRSA: susceptibility insights, Journal of Antimicrobial Chemotherapy, Volume 75, Issue 10, October 2020, Pages 2894–2901, https://doi.org/10.1093/jac/dkaa237
18. Abdul-Mutakabbir, J.C.; Kebriaei, R.; Stamper, K.C.; Sheikh, Z.; Maassen, P.T.; Lev, K.L.; Rybak, M.J. Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model. Antibiotics 2020, 9, 696.
19. Vanamala K, Tatiparti K, Bhise K, Sau S, Scheetz MH, Rybak MJ⃰, Andes D, Iyer AK. Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance. Drug Discov Today. 2021 Jan;26(1):31-43. doi: 10.1016/j.drudis.2020.10.011. Epub 2020 Oct 20. PMID: 33091564; PMCID: PMC7855522.
20. Razieh Kebriaei, Katherine Lev, Kyle Stamper, Susan M. Lehman, Sandra Morales, Rybak MJ. Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA strain: In vitro Pharmacokinetic/Pharmacodynamic Model. Antimicrob Agents Chemother. 2020 Dec 16;65(1): e01863-20. doi: 10.1128/AAC.01863-20. PMID: 33077648.
21. Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Beringer AW, Rodvold KA, Maples HD. Questions on Vancomycin dosing. Clin Infect Dis. 2020 Nov 26: ciaa1775. doi: 10.1093/cid/ciaa1775. Epub ahead of print. PMID: 33238295.
22. Taylor Morrisette, Katherine L. Lev, Razieh Kebriaei, Jacinda Abdul-Mutakabbir, Kyle C. Stamper, Sandra Morales, Susan M. Lehman, Gregory S. Canfield, Breck A. Duerkop, Gregory S. Canfield, Cesar A. Arias, Rybak MJ. Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities [published online ahead of print, 2020 Jun 22]. Antimicrob Agents Chemother. 2020;AAC.00993-20. doi:10.1128/AAC.00993-20
23. Morrisette T, Lodise TP, Scheetz MH, Goswami S, Pogue JM, Rybak MJ. The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse [published online ahead of print, 2020 Aug 1]. Infect Dis Ther. 2020;10.1007/s40121-020-00325-2. doi:10.1007/s40121-020-00325-2
24. Sara ALOSAIMY, Kyle P MURRAY, Evan J. ZASOWSKI, Taylor MORRISETTE, Abdalhamid M. LAGNF, Thomas P. LODISE, Rybak MJ. Vancomycin Area Under the Curve to Predict Timely Clinical Response in the Treatment of Methicillin-resistant Staphylococcus aureus Complicated Skin and Soft Tissue Infections [published online ahead of print, 2020 Jul 27]. Clin Infect Dis. 2020;ciaa1039. doi:10.1093/cid/ciaa1039
25. Morrisette T, Alosaimy S, Philley JV, Wadle C, Howard C, Webb AJ, Veve MP, Barger ML, Bouchard J, Gore TW, Lagnf AM, Ansari I, Mejia-Chew C, Cohen KA, Rybak MJ. Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections. Open Forum Infect Dis. 2021 Jan 7;8(2):ofab002. doi: 10.1093/ofid/ofab002. PMID: 33628856; PMCID: PMC7890947.
26. Rebold, N., Holger, D., Morrisette, T., Alosaimy, S., Rybak MJ. COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options. Infect Dis Ther (2021). https://doi.org/10.1007/s40121-021-00399-6
27. W Justin Moore, Andrew Webb, Taylor Morrisette, Louisa K Sullivan, Sara Alosaimy, Shahrier Hossain, Zachary Howe, Olga O Vlashyn, Frank P Paloucek, DABAT, Rybak MJ, Sheila Wang. Impact of COVID-19 pandemic on training of pharmacy residents and fellows: Results from a national survey of postgraduate pharmacy trainees, American Journal of Health-System Pharmacy, 2021; zxab114, https://doi.org/10.1093/ajhp/zxab114
28. Sara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, Sarah C J Jorgensen, Trang D Trinh, Evan J Zasowski, Marco R Scipione, Jing J Zhao, Ryan Mynatt, Shelbye Herbin, Sorabh Dhar, Teena Chopra, James Janisse, Nicholas Rebold, Jason M Pogue, Rybak MJ. Standardized Treatment and Assessment Pathway Improves Mortality in Adults with Methicillin-resistant Staphylococcus aureus Bacteremia: STAPH-Study, Open Forum Infectious Diseases, 2021;, ofab261,https://doi.org/10.1093/ofid/ofab261
29. Barber KE, Shmamout Z, SmithJR, Kebriaei R, Morrisette T, Rybak MJ. Biofilm time-kill curves to assess the bactericidal activity of daptomycin combinations against biofilm-producing vancomycin-resistant Enterococcus faecium and faecalis. Antibiotics (Basel). 2021. July23;10(8):897. doi: 10.3390/antibiotics10080897.
30. Morrisette T, Lev KL, Canfield GS, Duerkop BA, Kebriaei R, Stamper KC, Holger D, Lehman SM, Willcox S, Arias CA, Rybak MJ. Evaluation of bacteriophage cocktails alone and in combination with daptomycin against daptomycin-nonsusceptible Enterococcus faecium. Antimicrob Agent Chemother. 2021. Nov1:AAC016321. doi: 10.1128/AAC.01623-21.
31. Vanamala K, Bhise K, Sanchez H, Kebriaei R, Luong D, Sau S, Rybak MJ, Iyer AD. Folate functionalized lipid nanoparticles for targeted therapy of methicillin-resistant Staphylococcus aureus. Pharmaceutics. 2021. Oct 26;13(11):1791. doi: 10.3390/pharmaceutics1311791.

Link to PubMed